Lilly says depression drug didn’t meet goal in three studies – chicagotribune.com

Eli Lilly & Co. will end development of the depression medicine edivoxetine as an add-on therapy after the drug failed to meet goals in three studies.A current trial evaluating the experimental compound’s long-term effects will continue, the Indianapolis-based company said in a statement Thursday. Edivoxetine was in the final of three stages of testing usually required for marketing approval by U.S. regulators.

via Lilly says depression drug didn't meet goal in three studies – chicagotribune.com.

Related Posts
Filter by
Post Page
Mental Health News
Sort by

What’s The Deal With Depression Naps? | HuffPost

Spend some time scrolling through your social media feed and you’re likely to come across the term “depression nap
2018-01-09 16:40:07
deborah

0

Mediterranean Diet Improves Depression

Diet matters when it comes to mental health. When people with severe depression followed the Mediterranean diet,
2017-12-23 12:24:26
deborah

0

Link Shown Between Sinusitis, Hay Fever, and Depression | Psychology Today

Sinusitis (inflammation of the sinuses) and hay fever (allergic inflammation inside the nose) can certainly make you
2017-12-20 23:40:02
deborah

0

What Is Concealed Depression? | POPSUGAR Fitness

When you think of depression, you may be inclined to picture someone who struggles to get out of bed every morning
2017-12-14 17:01:46
deborah

0

You may also like